FDA Policy Power Challenged In House Questions On Untitled Letters
This article was originally published in The Pink Sheet Daily
Chairman Murphy wants to know if FDA is aware of consequences of publishing letters during stock trading hours.
You may also be interested in...
Response to congressional inquiry also notes that FDA's policy is not to make policy in untitled letters.
Appropriations report sets a deadline, but doesn't include a penalty for missing it as the House had with the opioid guidance last year.
FDA’s draft guidance on presenting product information on social media platforms with character space limitations includes an equation for sending a tweet.